A carregar...
Bortezomib treatment for severe refractory anti‐NMDA receptor encephalitis
OBJECTIVE: To evaluate the therapeutic potential of bortezomib, a proteasome inhibitor that target plasma cells, in order to revive stalled recovery in patients with anti‐N‐methyl‐d‐aspartate (NMDA) receptor encephalitis who remain bedridden even after aggressive immunotherapy. METHODS: We consecuti...
Na minha lista:
| Publicado no: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5945964/ https://ncbi.nlm.nih.gov/pubmed/29761122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.557 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|